Meeting
2015 Gastrointestinal Cancers Symposium
The feasibility and safety conversion surgery in stage IV gastric cancer.
Authors
Tsutomu Sato
Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama-shi, Japan
Tsutomu Sato , Ken Nishimura , Norisuke Nakayama , Osamu Motohashi , Kenki Segami , Shigeya Hayashi , Taiichi Kawabe , Toru Aoyama , Tsutomu Hayashi , Takanobu Yamada , Takashi Oshima , Yasushi Rino , Takashi Ogata , Haruhiko Cho , Takaki Yoshikawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 164)
DOI
10.1200/jco.2015.33.3_suppl.164
Abstract #
164
Poster Bd #
D12
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
The prognostic factor and the optimal timing of conversion surgery in unresectable stage IV gastric cancer: A retrospective analysis.
First Author: Tamotsu Sagawa
Poster
2020 ASCO Virtual Scientific Program
POF (paclitaxel/oxaliplatin/5-FU/leucovorin) versus SOX/CAPOX/FOLFOX as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer: Study protocol for a randomized controlled trial, FNF-014 trial.
First Author: Liyu Su
Poster
2020 Gastrointestinal Cancers Symposium
Survival benefit of conversion therapy after intensive chemotherapy for unresectable metastatic gastric cancer: A propensity score-matched analysis.
First Author: Hiroyuki Ohnuma
Poster
2018 ASCO Annual Meeting
International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1).
First Author: Masanori Terashima